title: [Pertussis vaccination coverage among adults in Germany].
abstract: BACKGROUND
  Pertussis vaccination for risk-groups (e. g. healthcare workers, employees of communal facilities, or persons with close contact to infants) has been recommended in Germany since 2001. In 2009, single-dose acellular pertussis (ap) vaccination was recommended for all adults at the next tetanus-diphtheria (Td) booster. Study aims were to assess 1) pertussis vaccination coverage in adults, and 2) use of tetanus-containing combination vaccines in hospitals.
  
  
  METHODS
  For 1) we analysed data from two population-based telephone surveys conducted among adults in Germany in 2009/2010 (GEDA09: n = 21,262; GEDA10: n = 22,050). Factors associated with vaccination were identified by logistic regression analyses. For 2) a questionnaire survey of 133 hospital pharmacies serving 454 German hospitals was undertaken for the year 2007.
  
  
  RESULTS
  Overall, 5.9% (95% confidence interval [CI] 5.5-6.3%) of GEDA10 participants reported up-to-date pertussis vaccination (ap-vaccination in past 10 years). In risk-groups, vaccination coverage was 10.7% (95%-CI 9.8-11.7%). Residence in former East-Germany and younger age were independently associated with an adequate vaccination status. Contrary to prevailing recommendations, ~75% of tetanus vaccines were administered as monovalent rather than Td- (or Tdap-)combination vaccines in hospitals.
  
  
  CONCLUSIONS
  In light of high pertussis-incidence and low vaccination coverage in German adults, improvement of pertussis vaccine uptake is vital, e. g. through awareness campaigns targeting both physicians in private practice and hospitals.
authors.affiliation: Fachgebiet Impfprävention, Robert Koch-Institut, Berlin, Germany. BoehmerM@rki.de
authors.forename: M M
authors.initials: MM
authors.lastname: Böhmer
authors.forename: W
authors.initials: W
authors.lastname: Hellenbrand
authors.forename: D
authors.initials: D
authors.lastname: Matysiak-Klose
authors.forename: U
authors.initials: U
authors.lastname: Heininger
authors.forename: S
authors.initials: S
authors.lastname: Müters
authors.forename: O
authors.initials: O
authors.lastname: Wichmann
mesh_terms: D000293:Adolescent; D000328:Adult; D003430:Cross-Sectional Studies; D005260:Female; D005858:Germany; D006293:Health Promotion; D006306:Health Surveys; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data*; D015994:Incidence; D008297:Male; D008875:Middle Aged; D010567:Pertussis Vaccine / Q000008:administration & dosage*; D014600:Utilization Review; D014917:Whooping Cough / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D055815:Young Adult
chemical_list: D010567:Pertussis Vaccine